Several oncogenes such as Myc and KRas have been shown to alter glutamine metabolism leading to glutamine dependence, although the outcome can be strongly tissue and context dependent and some cancer cells produce glutamine from glutamate through a reaction depending on glutamine synthetase (GS) (Tardito et al., 2015). Here, KRAS is linked to cancer.